Contact Information


For more information on the Rare Tumors Initiative or to become a member please contact:


Karlyne Reilly, Ph.D. Director, RTI and Head, Genetic Modifiers of Tumorigenesis Section, POB, CCR, NCI

Brigitte Widemann, M.D. Head, Pharmacology and Experimental Therapeutics Section, CCR, NCI

Abby Sandler, Ph.D. Special Assistant to the Director, Rare Tumors Initiative, OD, CCR, NCI

Last updated by Reilly, Karlyne (NIH/NCI) [E] on May 24, 2017